comparemela.com

Latest Breaking News On - அல்கான் ஆய்வகங்கள் இன்க் - Page 5 : comparemela.com

Alcon Inc Swiss: Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U S

Alcon Inc. Swiss: Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S. Vivity X-WAVE technology delivers extended range of vision while maintaining a monofocal-like visual disturbance profile 1,2 PC-IOL option for cataract patients who may not be a candidate for a diffractive IOL Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, has commercially launched the first and only non-diffractive extended depth of focus intraocular lens (IOL) in the U.S. the AcrySof IQ Vivity TM IOL (Vivity). This new presbyopia-mitigating lens is now available to all U.S. ophthalmologists for patients undergoing cataract surgery. Cataracts are the most common cause of vision loss globally.

Alcon Inc Investors: Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U S

Alcon Inc. Investors: Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S. Vivity X-WAVE technology delivers extended range of vision while maintaining a monofocal-like visual disturbance profile 1,2 PC-IOL option for cataract patients who may not be a candidate for a diffractive IOL Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, has commercially launched the first and only non-diffractive extended depth of focus intraocular lens (IOL) in the U.S. the AcrySof IQ Vivity TM IOL (Vivity). This new presbyopia-mitigating lens is now available to all U.S. ophthalmologists for patients undergoing cataract surgery. Cataracts are the most common cause of vision loss globally.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.